Tandem Diabetes Care, Inc. - Common Stock (NQ:TNDM)

19.50 +0.29 (+1.48%)

Delayed Quote Updated: 3:41 PM EDT, Oct 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tandem Diabetes Care, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

1 Growth Stock with All-Star Potential and 2 to Keep Off Your Radar

June 18, 2025

Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 will surely remember that the market’s...

Via StockStory

Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities

June 17, 2025

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:TNDM),(NYSE:NVO),(NASDAQ:PODD),(NYSE:MDT) EQNX::TICKER_END

Via FinancialNewsMedia

Earnings Scheduled For April 30, 2025 ↗

April 30, 2025

Via Benzinga

Novel Diagnostic Technology Disrupting Diabetic Retinopathy Market Generating Billions in Revenue Opportunities

June 17, 2025

From FN Media Group LLC

Via GlobeNewswire

Tandem Diabetes Inks Deal With Abbott For New Diabetes Solutions: Retail Sentiment Stays Subdued ↗

June 10, 2025

The agreement is to develop and commercialize integrated diabetes solutions that combine Abbott's future dual glucose-ketone sensor with San Diego, California- based Tandem's innovative insulin...

Via Stocktwits

Tandem Diabetes Care Announces Agreement with Abbott for Integration of Automated Insulin Delivery Systems with Future Glucose-Ketone Sensor

June 10, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges ↗

June 02, 2025

Goldman Sachs forecasts strong growth for diabetes tech, backing Dexcom and Insulet while rating Tandem and Beta Bionics as Neutral.

Via Benzinga

Reflecting On Healthcare Technology Stocks’ Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM)

May 26, 2025

Wrapping up Q1 earnings, we look at the numbers and key takeaways for the healthcare technology stocks, including Tandem Diabetes (NASDAQ:TNDM) and its peers.

Via StockStory

Where Tandem Diabetes Care Stands With Analysts ↗

May 22, 2025

Via Benzinga

Fortune Brands, Whirlpool, Align Technology, Tandem Diabetes, and STAAR Surgical Shares Plummet, What You Need To Know

May 21, 2025

A number of stocks fell in the afternoon session after the major indices pulled back (Nasdaq -1.3%, S&P 500 - 1.4%) as Treasury yields rose, reflecting market anxiety over a draft federal budget that...

Via StockStory

Topics Bonds Stocks

1 Momentum Stock with Impressive Fundamentals and 2 to Turn Down

May 16, 2025

The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to new product launches, positive news, or even a dedicated social media...

Via StockStory

TNDM Q1 Earnings Call: Product Expansion and Channel Initiatives Drive Growth Against Margin Pressures

May 14, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) announced better-than-expected revenue in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full...

Via StockStory

3 of Wall Street’s Favorite Stocks in Dangerous Territory

May 12, 2025

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional...

Via StockStory

Tandem Diabetes Care Announces Upcoming Conference Presentations

May 06, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care Stock: A Deep Dive Into Analyst Perspectives (10 Ratings) ↗

May 01, 2025

Via Benzinga

Tandem Diabetes’s (NASDAQ:TNDM) Q1: Beats On Revenue, Stock Soars

April 30, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects the full...

Via StockStory

Tandem Diabetes (NASDAQ:TNDM) Posts Better-Than-Expected Sales In Q1, Stock Soars

April 30, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 22.3% year on year to $234.4 million. The company expects...

Via StockStory

Tandem Diabetes Care Announces First Quarter 2025 Financial Results

April 30, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

Insights into Tandem Diabetes Care's Upcoming Earnings ↗

April 29, 2025

Via Benzinga

Tandem Diabetes (TNDM) Q1 Earnings Report Preview: What To Look For

April 29, 2025

Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting results tomorrow after the bell. Here’s what you need to know.

Via StockStory

Topics Artificial Intelligence

1 Volatile Stock Worth Your Attention and 2 to Keep Off Your Radar

April 22, 2025

Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced...

Via StockStory

Q4 Earnings Outperformers: Tandem Diabetes (NASDAQ:TNDM) And The Rest Of The Healthcare Technology Stocks

April 15, 2025

Let’s dig into the relative performance of Tandem Diabetes (NASDAQ:TNDM) and its peers as we unravel the now-completed Q4 healthcare technology earnings season.

Via StockStory

2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction ↗

April 12, 2025

Via The Motley Fool

Topics Artificial Intelligence Government World Trade

Forecasting The Future: 9 Analyst Projections For Tandem Diabetes Care ↗

April 10, 2025

Via Benzinga

Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry ↗

April 04, 2025

Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies...

Via Benzinga

Topics Government World Trade

Tandem Diabetes Care to Announce First Quarter 2025 Financial Results on April 30, 2025

April 03, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

3 Reasons to Sell TNDM and 1 Stock to Buy Instead

March 26, 2025

Shareholders of Tandem Diabetes would probably like to forget the past six months even happened. The stock dropped 54.1% and now trades at $20.22. This was partly driven by its softer quarterly results...

Via StockStory

Tandem Diabetes Care Announces NEJM Publication of Positive Pivotal Study Outcomes with Control-IQ+ AID Technology in Type 2 Diabetes

March 19, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

Tandem Diabetes Care Launches New Control-IQ+ Automated Insulin Delivery Technology in the United States

March 18, 2025

From Tandem Diabetes Care, Inc.

Via Business Wire

3 Healthcare Stocks Walking a Fine Line

March 18, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

< Previous 1 2 3 4 5 6 7 8 9

...

19 20 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.